secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATOSSA THERAPEUTICS, INC. (ATOS)
CIK:        0001488039
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0000950170-25-025596
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Atossa receives Nasdaq minimum bid price deficiency notice; compliance period through Aug 20, 2025
--------------------------------------------------------------------------------

- Received Nasdaq deficiency notice on Feb 21, 2025 for failing to maintain $1.00 minimum bid price for 30 consecutive business days.
- Compliance period ends Aug 20, 2025; possible additional 180-day extension if not compliant by then.
- To regain compliance, common stock must close at $1.00+ for at least 10 consecutive business days.
- Notice has no immediate effect on stock listing or trading; company monitoring and evaluating options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488039/000095017025025596/0000950170-25-025596-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488039/000095017025025596/atos-20250221.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-025596

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer